Novel potential causes of cancer revealed by NHS whole-genome study

Written by Rachel Jenkins: Senior Editor of Oncology Central

A recent study by researchers from the University of Cambridge (UK) has analyzed anonymised DNA data provided by the 100,000 Genomes Project, a UK-wide project to sequence the whole genomes of patients affected by cancer and rare diseases. The aim was to analyze mutational signatures in 12,000 tumors from NHS patients and compare the data to other international genetic cancer projects. The findings confirmed thousands of mutational signatures that are already known and revealed 58 new patterns, suggesting that there are other causes of cancer that are not fully understood.

Find out more about the software resources that the team has created to help physicians screen patients’ newly discovered genomic signatures in the full article on Oncology Central here!

 


Submit Your Research to the F1000Research Oncology Gateway

Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.

Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.